Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Conavi Medical Corp T.TMD

Healthcare Medical Devices
Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Conavi Medical Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Patg73123on Dec 10, 2010 12:41pm
256 Views
Post# 17829676

RE: RE: RE: RE: RE: RE: RE: daytrading???

RE: RE: RE: RE: RE: RE: RE: daytrading???I totally agree...here's the latest L2...look ma..no iceburgs..lol..and look who is bidding BUT this play has been done several times..remove the iceburgs, let the share price go up then slam it..

V:TMD Market Book By Order @12:41:36
Bid Ask
Spec Time Broker Size Price Price Size Broker Time Spec
12-10 08:21 1 10,000 1.34 1.35 1,500 99 12-10 12:20
12-10 09:43 85 2,950 1.34 1.35 500 99 12-10 12:21
12-10 12:20 14 1,400 1.34 1.36 3,500 33 12-10 11:45
12-10 09:43 85 2,000 1.33 1.36 500 99 12-10 12:21
12-10 09:43 85 900 1.33 1.39 3,000 80 12-10 10:34
12-10 07:24 7 2,000 1.32 1.40 6,129 19 12-09 15:37
12-10 09:43 85 1,500 1.32 1.42 3,800 2 12-10 09:24
12-10 09:43 85 2,500 1.32 1.42 3,500 85 12-10 10:19
12-10 12:25 5 1,500 1.32 1.42 930 7 12-10 12:14
12-10 12:27 5 3,000 1.32 1.42 3,000 85 12-10 12:17
12-10 07:59 1 1,000 1.31 1.43 1,000 1 12-10 07:48
12-10 10:13 7 8,461 1.31 1.43 18,500 9 12-10 08:39
12-10 10:13 7 3,000 1.31 1.44 3,600 85 12-09 15:31
12-10 10:35 15 5,000 1.31 1.44 2,800 85 12-09 15:34
12-10 12:20 85 2,600 1.31 1.44 2,300 79 12-09 15:46
12-10 12:24 15 10,000 1.31 1.44 3,700 85 12-10 08:20
12-10 12:35 15 10,000 1.31 1.45 25,000 78 12-09 10:33
12-10 09:00 14 1,000 1.30 1.45 100,000 7 12-09 14:53
12-10 09:46 15 500 1.30 1.45 9,000 9 12-10 10:00
12-10 10:52 85 635 1.30 1.46 3,500 14 12-10 12:37
12-10 10:52 85 15,350 1.30 1.47 3,600 85 12-10 08:21
12-10 12:37 85 750 1.30 1.47 3,000 85 12-10 09:23
12-08 09:32 89 5,000 1.29 1.48 1,000 1 12-10 07:48
12-08 10:37 9 8,000 1.29 1.49 1,400 85 12-10 09:35
12-10 10:52 85 5,000 1.28 1.50 5,000 7 12-09 14:29
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities